Daan Gene Co., Ltd. (002030.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 16Sep 21

Key dataSep 21, 2026

OpenCNY 5.43

From 52W high−30.09%

Volume35.56M

Market capCNY 7.57B

P/E (TTM)−10.2x

P/S (TTM)10.7x

Div yield—

Key dataSep 21, 2026

Open

CNY 5.43

From 52W high

−30.09%

Volume

35.56M

Market cap

CNY 7.57B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−17.5x

P/E (TTM)

−10.2x

RSI (14)

56.2

MomentumView details →

1D Return

−3.75%

YTD Return

−5.70%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−10.2x

EV/EBITDA

−17.5x

EV/Sales

10.5x

P/S (TTM)

10.7x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

32.38%

Net Margin

−121.34%

EBITDA Margin

−59.91%

ROE (TTM)

−12.72%

ROA (TTM)

−10.74%

Asset Turnover

0.09x

GrowthView details →

Revenue YoY

−10.43%

EPS YoY

−76.97%

FCF YoY

−56.24%

Revenue CAGR 3Y

−60.23%

EPS CAGR 3Y

+19.70%

EBITDA YoY

—

MomentumView details →

1D Return

−3.75%

YTD Return

−5.70%

1Y Return

−10.22%

RSI (14)

56.2

vs 50D SMA

+2.89%

vs 200D SMA

−5.46%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

2.98x

Quick Ratio

2.82x

Div Yield

—

Div Rate

—

Div Growth 1Y

−99.14%

EarningsView details →

EPS (Actual)

−CNY 0.02

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

737.96M

Net Income (TTM)

−895.46M

Op. CF (TTM)

310.55M

Next earningsOct 29, 2026 →

Latest newsMore news →

Da An Gene announced its first-half 2026 results, reporting a net loss of 120 million yuan, an improvement from a loss of 182 million yuan in the same period of 2025.24d ago

Da An Gene and others jointly established Zhongda Synthetic Biotechnology (Guangzhou) Co., Ltd., a new company focused on synthetic biology research and development.28d ago

Similar companies

中颖电子300327.SZ 电光科技002730.SZ 大为股份002213.SZ 金一文化002721.SZ 顺鑫农业000860.SZ 翔楼新材301160.SZ Find similar companies →

Latest newsMore news →

Da An Gene announced its first-half 2026 results, reporting a net loss of 120 million yuan, an improvement from a loss of 182 million yuan in the same period of 2025.24d ago Da An Gene and others jointly established Zhongda Synthetic Biotechnology (Guangzhou) Co., Ltd., a new company focused on synthetic biology research and development.28d ago